| |
| |
|
| Insider
Information: |
Schimmel Paul |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,717,702 |
|
|
Indirect Shares
|
1,312,785 |
|
|
| Direct
Value |
$114,750,305 |
|
|
|
Indirect Value
|
$45,782,333 |
|
|
| Total
Shares |
3,030,487 |
|
|
| Total
Value |
$160,532,638 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-03-13 |
0 |
2018-03-13 |
306,996 |
Premium* |
|
|
Repligen Corp |
RGEN |
Director |
2007-06-14 |
665,106 |
2005-11-07 |
0 |
Premium* |
|
|
Avicena Group, Inc. |
AVCE |
Director |
2006-12-28 |
1,020,242 |
2005-11-23 |
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Director |
2023-05-10 |
8,890 |
2023-05-10 |
992,166 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
Director |
2017-04-19 |
23,464 |
2017-04-19 |
13,623 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2004-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,578 |
237,893 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2005-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
121 |
238,014 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2005-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
74 |
238,088 |
|
- |
|
| AVCE |
Avicena Group, Inc. |
Director |
– • – |
2005-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
33,242 |
1,205,242 |
|
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2015-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
547,353 |
646,167 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Director |
– • – |
2017-04-19 |
4 |
A |
$0.00 |
$0 |
I/I |
11,363 |
3,623 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
Director |
– • – |
2017-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
23,464 |
23,464 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2019-04-12 |
4 |
A |
$0.54 |
$1,000,000 |
I/I |
1,848,428 |
2,570,242 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2013-10-22 |
4 |
AS |
$60.00 |
$900,000 |
D/D |
(15,000) |
126,216 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2013-12-20 |
4 |
AS |
$65.00 |
$975,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2014-01-13 |
4 |
AS |
$85.36 |
$1,280,400 |
D/D |
(15,000) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2014-10-28 |
4 |
AS |
$95.00 |
$1,425,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2014-12-08 |
4 |
AS |
$105.00 |
$1,575,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2015-03-17 |
4 |
AS |
$120.00 |
$113,640 |
D/D |
(947) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2015-03-19 |
4 |
AS |
$120.00 |
$1,086,360 |
D/D |
(9,053) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2015-04-21 |
4 |
AS |
$130.02 |
$1,300,200 |
D/D |
(10,000) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-03-13 |
4 |
AS |
$150.00 |
$4,173,450 |
D/D |
(27,823) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
officerTitle |
– • – |
2006-01-31 |
4 |
B |
$13.00 |
$1,300,000 |
I/I |
100,000 |
338,088 |
2.1 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-04-05 |
4 |
B |
$3.52 |
$88,118 |
D/D |
25,000 |
37,572 |
2.39 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-04-06 |
4 |
B |
$3.20 |
$80,000 |
D/D |
25,000 |
62,572 |
2.39 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-04-07 |
4 |
B |
$3.19 |
$127,584 |
D/D |
40,000 |
102,572 |
2.39 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-04-08 |
4 |
B |
$3.22 |
$273,649 |
D/D |
85,000 |
187,572 |
2.39 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-04-11 |
4/A |
B |
$3.45 |
$97,643 |
I/I |
27,400 |
233,581 |
2.1 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-04-11 |
4/A |
B |
$3.59 |
$18,891 |
D/D |
5,259 |
17,831 |
2.39 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-04-11 |
4 |
B |
$3.45 |
$116,535 |
D/D |
32,659 |
220,231 |
2.39 |
- |
|
84 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
